ESTEPAN IAN MICHAEL (Chief Financial Officer) received a stock award from SAREPTA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/11/2025ACC: 0000950170-25-037519
Officer· Chief Financial Officer
Since Dec 2020
+20.98K
Net shares
Net buyer
$394.6K
Total sold
0
Open market trades
0B · 0S
6
Total transactions
30.42K acquired · 9.44K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+5.50K
Price / share
—
Trade value
—
% of position
10.4%
3/7/2025
52.78K→58.28K
Common Stock
Direct
Shares
−1.05K
Price / share
$100.13
Trade value
$105.24K
% of position
1.8%
3/10/2025
58.28K→57.23K
Common Stock
Direct
Shares
−2.89K
Price / share
$100.13
Trade value
$289.38K
% of position
5.1%
3/10/2025
57.23K→54.34K
Common Stock
Direct
Shares
+8.28K
Price / share
—
Trade value
—
% of position
15.2%
3/10/2025
54.34K→62.61K
Total
Net shares
+9.84K
Net value
-$394.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/7/2025 | M · Option Exercise | +5.50K | — | — | 10.4% | 52.78K | 58.28K |
| Common Stock Direct | 3/10/2025 | F · Tax Withholding | −1.05K | $100.13 | $105.24K | 1.8% | 58.28K | 57.23K |
| Common Stock Direct | 3/10/2025 | F · Tax Withholding | −2.89K | $100.13 | $289.38K | 5.1% | 57.23K | 54.34K |
| Common Stock Direct | 3/10/2025 | A · Award | +8.28K | — | — | 15.2% | 54.34K | 62.61K |
| Total | +9.84K | -$394.61K | ||||||
Derivative Transactions2
Performance Stock Units
Direct
Converts to
Common Stock
5.50K shares
Shares
−5.50K
Strike price
Held after
0.00
Exercisable
—
3/7/2025
Stock Options (right to buy)
Direct
Converts to
Common Stock
16.64K shares
Shares
+16.64K
Strike price
99.69
Held after
16.64K
Exercisable
—
3/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Stock Units Direct | Common Stock5.50K shares | 3/7/2025 | M · Option Exercise | −5.50K | — | 0.00 | |
| Stock Options (right to buy) Direct | Common Stock16.64K shares | 3/10/2025 | A · Award | +16.64K | 99.69 | — | 16.64K |